Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch and Maintenance Study of Intravenous R744 in Hemodialysis Patients
jRCT2080220346Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Carbon dioxide in end-stage kidney disease (ESKD), sponsored by Chugai Pharmaceutical Co., Ltd.
02
Drugs
Carbon dioxide
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on jRCT2080220346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220346.